Jason Bock, PhD.

Scientific Advisor

Jason is CEO of CTMC in Houston, TX, a joint venture between Resilience + MD Anderson Cancer Center, which was conceived to accelerate patient access to impactful cell therapies. He brings over 20 years of previous biologics development and commercialization experience at MD Anderson, Teva Pharmaceuticals, CoGenesys, and Human Genome Sciences.